{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:50:56Z","timestamp":1791921056911,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430122"],"award-info":[{"award-number":["82430122"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273197"],"award-info":[{"award-number":["82273197"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403832"],"award-info":[{"award-number":["82403832"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BG2024007"],"award-info":[{"award-number":["BG2024007"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0520100"],"award-info":[{"award-number":["2024ZD0520100"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phymed.2026.158855","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:31:20Z","timestamp":1791066680000},"page":"158855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Modulating pMMR colorectal tumors toward a dMMR-like phenotype by Xian-Lian-Jie-Du decoction enhances anti-PD-1 efficacy"],"prefix":"10.1016","volume":"162","author":[{"given":"Yufeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinchang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-3905","authenticated-orcid":false,"given":"Wenjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2026.158855_bib0001","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41571-025-01015-z","article-title":"Epidemiology, pathogenesis, biology and evolving management of MSI-H\/dMMR cancers","volume":"22","author":"Ambrosini","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0002","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0003","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/s41467-022-29442-x","article-title":"Ubiquitin ligase STUB1 destabilizes IFN\u03b3-receptor complex to suppress tumor IFN\u03b3 signaling","volume":"13","author":"Apriamashvili","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phymed.2026.158855_bib0004","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2026.158855_bib0005","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.3390\/cancers13246311","article-title":"Combined treatment with immunotherapy-based strategies for MSS metastatic colorectal cancer","volume":"13","author":"Baraibar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.phymed.2026.158855_bib0006","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0007","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/j.gastro.2019.03.071","article-title":"Methylation tolerance-based functional assay to assess variants of unknown significance in the MLH1 and MSH2 genes and identify patients with Lynch syndrome","volume":"157","author":"Bouvet","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2026.158855_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155385","article-title":"Xianlian Jiedu Decoction alleviates colorectal cancer by regulating metabolic profiles, intestinal microbiota and metabolites","volume":"128","author":"Cai","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158855_bib0009","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamaoncol.2020.0910","article-title":"Effect of combined immune checkpoint inhibition vs best supportive care alone in patients with advanced colorectal cancer: the Canadian Cancer Trials Group CO.26 study","volume":"6","author":"Chen","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41591-021-01581-6","article-title":"Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency","volume":"28","author":"Das","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0011","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.phymed.2026.158855_bib0012","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11658-024-00547-z","article-title":"MRE11A: a novel negative regulator of human DNA mismatch repair","volume":"29","author":"Du","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.phymed.2026.158855_bib0013","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1158\/2159-8290.CD-20-1571","article-title":"Loss of optineurin drives cancer immune evasion via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation","volume":"11","author":"Du","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2026.158855_bib0014","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2026.158855_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12906-023-04052-2","article-title":"Efficacy and safety of Xian-Lian-Jie-Du optimization decoction as an adjuvant treatment for prevention of recurrence in patients with stage IIIB\/IIIC colon cancer: study protocol for a multicentre, randomized controlled trial","volume":"23","author":"Geng","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"10.1016\/j.phymed.2026.158855_bib0016","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature24673","article-title":"Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth","volume":"552","author":"Germano","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158855_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2026.158855_bib0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","article-title":"Conserved interferon-\u03b3 signaling drives clinical response to immune checkpoint blockade therapy in melanoma","volume":"38","author":"Grasso","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2026.158855_bib0019","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","article-title":"Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC","volume":"383","author":"Herbst","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0020","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cell.2011.10.025","article-title":"Visualization of eukaryotic DNA mismatch repair reveals distinct recognition and repair intermediates","volume":"147","author":"Hombauer","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158855_bib0021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phymed.2026.158855_bib0022","article-title":"Modulation of immune checkpoints by chemotherapy in human colorectal liver metastases","volume":"1","author":"Jabbari","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0023","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","article-title":"Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"Kato","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0024","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.cell.2013.10.015","article-title":"The landscape of microsatellite instability in colorectal and endometrial cancer genomes","volume":"155","author":"Kim","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2026.158855_bib0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.gastro.2022.11.018","article-title":"N-glycosylation regulates intrinsic IFN-\u03b3 resistance in colorectal cancer: implications for immunotherapy","volume":"164","author":"Krug","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2026.158855_bib0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phymed.2026.158855_bib0026","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41586-022-04585-5","article-title":"CAR T cell killing requires the IFN\u03b3R pathway in solid but not liquid tumours","volume":"604","author":"Larson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158855_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2026.158855_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188447","article-title":"Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside","volume":"1874","author":"Lizardo","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.phymed.2026.158855_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/jpet.120.000284","article-title":"Downregulation of interferon-\u03b3 receptor expression endows resistance to anti-programmed death protein 1 therapy in colorectal cancer","volume":"376","author":"Lv","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phymed.2026.158855_bib0031","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0032","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11864-021-00870-z","article-title":"Beyond microsatellite instability: evolving strategies integrating immunotherapy for microsatellite stable colorectal cancer","volume":"22","author":"Pecci","year":"2021","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.phymed.2026.158855_bib0034","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1093\/nar\/gkad156","article-title":"Synergistic binding of actinomycin D and echinomycin to DNA mismatch sites and their combined anti-tumour effects","volume":"51","author":"Satange","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phymed.2026.158855_bib0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/14712598.2021.1933940","article-title":"Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?","volume":"21","author":"Wang","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.phymed.2026.158855_bib0036","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12272-021-01355-1","article-title":"Advances in plant-derived natural products for antitumor immunotherapy","volume":"44","author":"Yang","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2026.158855_bib0037","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2147\/JIR.S344861","article-title":"Identification of significant modules and targets of Xian-Lian-Jie-Du Decoction based on the analysis of transcriptomics, proteomics and single-cell transcriptomics in colorectal tumor","volume":"15","author":"Yu","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.phymed.2026.158855_bib0038","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/acsnano.0c00708","article-title":"Icaritin exacerbates mitophagy and synergizes with doxorubicin to induce immunogenic cell death in hepatocellular carcinoma","volume":"14","author":"Yu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.phymed.2026.158855_bib0039","doi-asserted-by":"crossref","first-page":"12511","DOI":"10.1021\/acsnano.9b02875","article-title":"Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.phymed.2026.158855_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.158482","article-title":"Xian-Lian-Jie-Du Decoction suppresses colorectal cancer liver metastasis by inhibiting Plaur\/Hbegf\/EGFR-mediated actin cytoskeleton remodeling","volume":"159","author":"Zhang","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.158855_bib0041","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion-positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N. Engl. J. Med."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326010846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:29:39Z","timestamp":1791919779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326010846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":41,"alternative-id":["S0944711326010846"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158855","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating pMMR colorectal tumors toward a dMMR-like phenotype by Xian-Lian-Jie-Du decoction enhances anti-PD-1 efficacy","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.158855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"158855"}}